Trade XENE anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Xenon Pharmaceuticals Inc. Common Shares (XENE) is trading at US$59.75, down 1.08% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$5.88B. Over the past 52 weeks, XENE has traded between US$35.60 and US$72.66. On Syfe you can trade XENE with $0 commission and add it to your watchlist.
| Previous close | US$60.40 |
|---|---|
| Market cap | US$5.88B |
| 52-week range | US$35.60 – US$72.66 |
| Volume | 459.13K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Xenon Pharmaceuticals Inc. Common Shares
Xenon Pharmaceuticals, Inc. is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.
Year: 2014
Stay on top of XENE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
